RNA disruption indicates CHOP therapy efficacy in canine lymphoma.

Amadeo M ParissentiLaura B PritzkerBaoqing GuoRashmi NarendrulaShirly Xiaohui WangLin Laura LinJingchun PeiKarolina SkowronskiDorothee BienzleJ Paul WoodsKenneth P H PritzkerBrenda L Coomber

Published in: BMC veterinary research (2019)

Predicting the risk of early relapse during chemotherapy could benefit veterinary patients by reducing ineffective treatment and could allow veterinary oncologists to switch earlier to a more effective drug regimen.

Keyphrases

end stage renal disease
diffuse large b cell lymphoma
chronic kidney disease
ejection fraction
peritoneal dialysis
prognostic factors
stem cells
bone marrow
drug induced
adverse drug